These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6308380

  • 1. Hepatocellular carcinoma in a patient with sarcoidosis-associated chronic active hepatitis and the MZ alpha-1-antitrypsin phenotype.
    Kronborg IJ, Bhathal PS, Mackay IR, Storey E, Long TM.
    Liver; 1983 Apr; 3(2):92-9. PubMed ID: 6308380
    [Abstract] [Full Text] [Related]

  • 2. Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency.
    Marwick TH, Cooney PT, Kerlin P.
    Pathology; 1985 Oct; 17(4):649-52. PubMed ID: 3005953
    [Abstract] [Full Text] [Related]

  • 3. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis.
    Hodges JR, Millward-Sadler GH, Barbatis C, Wright R.
    N Engl J Med; 1981 Mar 05; 304(10):557-60. PubMed ID: 6969850
    [Abstract] [Full Text] [Related]

  • 4. Alpha-1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults.
    Vecchio FM, Fabiano A, Orsini G, Ragusa D, Massi G.
    Digestion; 1983 Mar 05; 27(2):100-4. PubMed ID: 6354808
    [Abstract] [Full Text] [Related]

  • 5. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
    Elzouki AN, Eriksson S.
    Eur J Gastroenterol Hepatol; 1996 Oct 05; 8(10):989-94. PubMed ID: 8930564
    [Abstract] [Full Text] [Related]

  • 6. alpha 1-Antitrypsin deficiency and hepatocellular carcinoma. Association with cirrhosis, copper storage, and Mallory bodies.
    Rubel LR, Ishak KG, Benjamin SB, Knuff TE.
    Arch Pathol Lab Med; 1982 Dec 05; 106(13):678-81. PubMed ID: 6291490
    [Abstract] [Full Text] [Related]

  • 7. Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of alpha 1-antitrypsin.
    Reid CL, Wiener GJ, Cox DW, Richter JE, Geisinger KR.
    Gastroenterology; 1987 Jul 05; 93(1):181-7. PubMed ID: 3034714
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W.
    J Hepatol; 1994 Dec 05; 21(6):1006-11. PubMed ID: 7699220
    [Abstract] [Full Text] [Related]

  • 9. Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).
    Lieberman J, Silton RM, Agliozzo CM, McMahon J.
    Am J Clin Pathol; 1975 Sep 05; 64(3):304-10. PubMed ID: 169686
    [Abstract] [Full Text] [Related]

  • 10. alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma.
    Govindarajan S, Ashcavai M, Peters RL.
    Hepatology; 1981 Sep 05; 1(6):628-31. PubMed ID: 6171495
    [Abstract] [Full Text] [Related]

  • 11. Alpha-1 antitrypsin deficiency in patients with chronic hepatitis.
    Şımşek H, Pinar A, Altinbaş A, Alp A, Balaban YH, Büyükaşik Y, Özcebe O, Hasçelık G, Gedıkoğlu G, Tatar G.
    Turk J Gastroenterol; 2012 Sep 05; 23(5):569-73. PubMed ID: 23161303
    [Abstract] [Full Text] [Related]

  • 12. Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency.
    Eriksson S, Hägerstrand I.
    Acta Med Scand; 1974 Jun 05; 195(6):451-8. PubMed ID: 4365922
    [No Abstract] [Full Text] [Related]

  • 13. Hepatocellular carcinoma associated with autoimmune chronic active hepatitis.
    Thung SN, Bach N, Fasy TM, Jordon D, Schaffner F.
    Mt Sinai J Med; 1990 May 05; 57(3):165-8. PubMed ID: 2164643
    [Abstract] [Full Text] [Related]

  • 14. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
    Rabinovitz M, Gavaler JS, Kelly RH, Prieto M, Van Thiel DH.
    Hepatology; 1992 Mar 05; 15(3):407-10. PubMed ID: 1312055
    [Abstract] [Full Text] [Related]

  • 15. An association between alpha 1-antitrypsin phenotype and chronic liver disease.
    Kishimoto Y, Yamada S, Hirayama C.
    Hum Genet; 1990 Jan 05; 84(2):132-6. PubMed ID: 2153626
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ).
    Rawlings W, Moss J, Cooper HS, Hamilton SR.
    Ann Intern Med; 1974 Dec 05; 81(6):771-3. PubMed ID: 4372920
    [No Abstract] [Full Text] [Related]

  • 17. Alpha-1-antitrypsin deficiency and liver disease.
    Millward-Sadler GH.
    Acta Med Port; 1981 Dec 05; (Suppl 2):91-102. PubMed ID: 6263065
    [No Abstract] [Full Text] [Related]

  • 18. Alpha 1-antitrypsin in patients with hepatocellular carcinoma and chronic active hepatitis.
    Fargion S, Klasen EC, Lalatta F, Sangalli G, Tommasini M, Fiorelli G.
    Clin Genet; 1981 Feb 05; 19(2):134-9. PubMed ID: 6258829
    [Abstract] [Full Text] [Related]

  • 19. [Liver and hereditary alpha 1-antitrypsin deficiency].
    Feldmann G.
    Gastroenterol Clin Biol; 1993 Feb 05; 17(2):83-93. PubMed ID: 8388836
    [No Abstract] [Full Text] [Related]

  • 20. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria.
    Olusi SO.
    Trop Geogr Med; 1990 Jan 05; 42(1):41-6. PubMed ID: 2175465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.